Global Cancer Pain Market

Cancer Pain Market Size, Share, Growth Analysis, By Drug(Opioids, Morphine, Fentanyl, Others), By Disease Indication(Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35J2075 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 71 | Figures: 65

Cancer Pain Market News

  • In March 2024, Metis Global Partners LLC unveiled that it raised its stake in Microsoft Co. by 16.3% during the third quarter, as detailed in its most recent exposure with the SEC.

     

  • In February 2024, Radformation, a main supplier of radiation oncology software solutions, declared its strategic partnership with Icon Group (Icon), a worldwide leader in comprehensive cancer care. This collaboration unites the aptitude of the two organizations to change disease care through imaginative work processes and high-level software solutions.

     

  • In January 2024, Quibim, an organization working on changing imaging data into significant actionable data for cancer growth and treatment responses, collaborated with Merck KGaA. The collaboration means fostering high-level imaging-based diagnostics for accurate medication.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cancer Pain Market size was valued at USD 6.55 billion in 2022 and is poised to grow from USD 6.92 billion in 2023 to USD 10.70 billion by 2031, growing at a CAGR of 5.6% in the forecast period (2024-2031).

The competitive landscape of the cancer pain market is characterized by a diverse array of pharmaceutical and healthcare companies striving to offer innovative solutions for effective pain management. Established players such as Pfizer, Johnson & Johnson, Purdue Pharma, and Novartis maintain a strong presence, leveraging their extensive research capabilities and product portfolios. These companies often collaborate with medical institutions to advance pain management technologies and therapies. 'Pfizer (USA)', 'Johnson & Johnson (USA)', 'Purdue Pharma (USA)', 'Novartis (Switzerland)', 'Heron Therapeutics (USA)', 'Teva Pharmaceutical Industries (Israel)', 'Eli Lilly and Company (USA)', 'AstraZeneca (UK)', 'GlaxoSmithKline (UK)', 'Merck & Co., Inc. (USA0'

Technological innovations in pain management techniques, drug delivery systems, and personalized treatments enhance the efficacy and accessibility of cancer pain management.

Personalized Pain Management: Increasing focus on individualized treatment approaches based on genetic and molecular profiles is shaping the direction of cancer pain management.

In 2022, North America played a pivotal role in the cancer pain market, capturing a substantial share, and this influential position is anticipated to persist throughout the forecast period. The region's continued prominence is underpinned by several factors including the escalating prevalence of cancer cases, continuous technological advancements in the healthcare sector, the convenient accessibility of pain management therapies, and the availability of top-tier chemotherapy treatment options. These factors collectively contribute to North America's stronghold in driving the growth of the cancer pain market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Pain Management Market
Buy Now GET FREE SAMPLE
Breast Cancer Market
Buy Now GET FREE SAMPLE
Cancer Cachexia Market
Buy Now GET FREE SAMPLE
Tumor Ablation Market
Buy Now GET FREE SAMPLE
Cancer Diagnostics Market
Buy Now GET FREE SAMPLE
Oncology Market
Buy Now GET FREE SAMPLE
Neuropathic Pain Market
Buy Now GET FREE SAMPLE
Cancer Supportive Care Drugs Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Cancer Pain Market

Report ID: SQMIG35J2075

$5,300
BUY NOW GET FREE SAMPLE